Brodalumab for the treatment of moderate‐to‐severe plaque‐type psoriasis: a real‐life, retrospective 24‐week experience - Concepedia

Concepedia

Publication | Closed Access

Brodalumab for the treatment of moderate‐to‐severe plaque‐type psoriasis: a real‐life, retrospective 24‐week experience

38

Citations

24

References

2020

Year

Maria Concetta Fargnoli, Maria Esposito, Paolo Dapavo, Aurora Parodi, Mariateresa Rossi, R. Tiberio, Stefano Dastoli, Anna Maria Offidani, Giuseppe Argenziano, Paolo Gisondi,

Journal of the European Academy of Dermatology and Venereology

Abstract

Brodalumab is effective and safe in the treatment of moderate-to-severe psoriasis in a real-world setting, including in patients with failure to anti-IL17 therapies.

References

	Year	Citations

Page 1